0001526335-15-000002.txt : 20150619
0001526335-15-000002.hdr.sgml : 20150619
20150619095122
ACCESSION NUMBER: 0001526335-15-000002
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150617
FILED AS OF DATE: 20150619
DATE AS OF CHANGE: 20150619
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARGOS THERAPEUTICS INC
CENTRAL INDEX KEY: 0001105533
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 562110007
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4233 TECHNOLOGY DR
CITY: DURHAM
STATE: NC
ZIP: 27704
BUSINESS PHONE: 9192876300
MAIL ADDRESS:
STREET 1: 4233 TECHNOLOGY DR
CITY: DURHAM
STATE: NC
ZIP: 27704
FORMER COMPANY:
FORMER CONFORMED NAME: MERIX BIOSCIENCE INC
DATE OF NAME CHANGE: 20000207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Underdown Brian J.
CENTRAL INDEX KEY: 0001526335
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35443
FILM NUMBER: 15941526
MAIL ADDRESS:
STREET 1: C/O LUMIRA CAPITAL INVESTMENT MANAGEMENT
STREET 2: 141 ADELAIDE ST. WEST, SUITE 770
CITY: TORONTO ONTARIO CANADA M5H 3L5
STATE: A6
ZIP: 00000
4/A
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4/A
2015-06-17
2015-06-18
0
0001105533
ARGOS THERAPEUTICS INC
ARGS
0001526335
Underdown Brian J.
C/O LUMIRA CAPITAL INVESTMENT MANAGEMENT
141 ADELAIDE ST. WEST, SUITE 770
TORONTO ONTARIO CANADA M5H 3L5
A6
00000
ONTARIO, CANADA
1
0
0
0
Stock Option (right to buy)
7.8
2015-06-17
4
A
0
5500
0
A
2025-06-16
Common Stock
5500
5500
D
This option was granted on June 17, 2015 and vests in equal amounts quarterly over the 12 month period beginning June 17, 2015.
Lori R. Harrelson, as attorney-in-fact
2015-06-19